[1]高艳超,王 岩,柳 越,等.绝经后骨质疏松患者血清SIK2，SMURF1 表达水平及其与骨代谢、骨密度指标的相关性研究[J].现代检验医学杂志,2023,38(04):110-115.[doi:10.3969/j.issn.1671-7414.2023.04.020]
　GAO Yanchao,WANG Yan,LIU Yue,et al.Expression of Serum SIK2 and SMURF1 in Postmenopausal Osteoporosis Patients and Their Correlation with Bone Metabolism and Bone Mineral Density[J].Journal of Modern Laboratory Medicine,2023,38(04):110-115.[doi:10.3969/j.issn.1671-7414.2023.04.020]
点击复制

绝经后骨质疏松患者血清SIK2，SMURF1 表达水平及其与骨代谢、骨密度指标的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年04期
页码:
110-115
栏目:
论著
出版日期:
2023-07-15

文章信息/Info

Title:
Expression of Serum SIK2 and SMURF1 in Postmenopausal Osteoporosis Patients and Their Correlation with Bone Metabolism and Bone Mineral Density
文章编号:
1671-7414（2023）04-110-06
作者:
高艳超; 王 岩; 柳 越; 孙永艳
（朝阳市第二医院内分泌科，辽宁朝阳 122000）
Author(s):
GAO Yanchao;  WANG Yan;  LIU Yue;  SUN Yongyan
（Department of Endocrinology, the Second Hospital of Chaoyang , Liaoning Chaoyang 122000，China）
关键词:
绝经后骨质疏松; 盐诱导激酶2; Smad 泛素化调节因子1; 骨代谢; 骨密度
分类号:
R591.1；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.04.020
文献标志码:
A
摘要:
目的　探讨绝经后骨质疏松(postmenopausal osteoporosis，PMOP) 患者血清盐诱导激酶2（salt-inducible kinase 2，SIK2）、Smad 泛素化调节因子1（Smad ubiquitination regulatory factor 1，SMURF1）表达水平与骨代谢、骨密度的相关性。方法　选取朝阳市第二医院2019 年4 月～ 2021 年4 月收治的154 例绝经后骨质疏松患者作为研究组，另选取该院同期体检的绝经后健康女性150 例作为对照组。用定量逆转录聚合酶链式反应（reverse transcription-polymerasechain reaction，RT-PCR）法检测两组血清SIK2 和SMURF1 相对表达水平；Pearson 相关分析明确血清SIK2，SMURF1与骨代谢指标、骨密度的相关性；Logistic 回归分析绝经后骨质疏松的影响因素；受试者工作特征（ROC）曲线分析血清SIK2 和SMURF1 对绝经后骨质疏松的预测价值。结果　与对照组相比，研究组腰椎L1~4 骨密度（0.71±0.20 g/cm3 vs 0.86±0.21 g/cm3）、25 羟基维生素D[（25-hydroxyvitamin D，25-OH-D）（12.07±2.76 ng/ml vs 14.31±2.62ng/ml）] 和股骨颈骨密度（0.61±0.18 g/cm3 vs 0.82±0.19 g/cm3）水平均显著降低，差异均有统计学意义（t=6.378，7.254，9.895，均P<0.001）；血清骨桥蛋白（osteopontin，OPN）（18.67±3.17 ng/ml vs 16.78±2.69 ng/ml）、甲状旁腺素（parathyroid hormone，PTH）（71.26±8.88 pg/ml vs 64.31±8.24 pg/ml）、SIK2（0.94±0.16 vs 0.79±0.17）、Ⅰ型胶原羧基端肽β 特殊序列（bate C-terminal cross-linked telopeptids of type Ⅰ collagen，β-CTx）（5.12±0.96 pg/ml vs4.28±0.84 pg/ml）、骨钙素（osteocalcin，OC）（15.64±2.73 ng/ml vs 13.28±2.14 ng/ml）、Ⅰ型胶原氨基端前肽（N-terminalpropeptide of typeⅠ procollagen，PINP）（41.28±4.68 ng/ml vs 36.47±4.62 ng/ml） 及SMURF1（0.93±0.22 vs 0.66±0.16） 水平显著升高， 差异均有统计学意义（t=5.598 ～ 11.759， 均P<0.001）。血清SIK2 ，SMURF1 与OPN，OC，SMURF1，β-CTx，PINP 均呈正相关（rSIK2=0.169 ～ 0.292，rSMURF1=0.194 ～ 0.246，均P<0.05）；血清SIK2，SMURF1 与25-OH-D，股骨颈骨密度呈负相关（rSIK2=-0.212，-0.210；rSMURF1=-0.285，-0.252，均P<0.05）。股骨颈骨密度（OR=0.002，P<0.05），OPN（OR=1.592，P<0.05），OC（OR=1.603，P<0.05），PINP（OR=1.675，P<0.05），SIK2（OR=310.221，P<0.001）和SMURF1（OR=1359.044，P<0.001）是绝经后骨质疏松的影响因素。二者联合预测绝经后骨质疏松ROC 曲线下面积（AUC）显著大于SIK2 单独预测的AUC（Z=3.339，P<0.001），与SMURF1 单独预测的AUC 差异无统计学意义（P>0.05）。结论　绝经后骨质疏松患者血清SIK2 和SMURF1 水平均明显升高，二者均与患者骨代谢指标、骨密度密切相关。
Abstract:
Objective　To investigate the correlation between the expression levels of serum Salt-inducible kinase 2 (SIK2) and Smad ubiquitination regulator 1 (SMURF1), and bone metabolism and bone mineral density in patients with postmenopausal osteoporosis. Methods　A total of 154 patients with postmenopausal osteoporosis admitted to the Second Hospital of Chaoyang from April 2019 to April 2021 were selected as the study group, and 150 healthy postmenopausal women who underwent physical examination in the same period were selected as the control group. The relative expression levels of serum SIK2 and SMURF1 were detected by quantitative reverse transcription-polymerase chain reaction (RT-PCR). Pearson correlation analysis was used to determine the correlation between serum SIK2 and SMURF1 and bone metabolism index and bone mineral density. Logistic regression analysis was used to analyze the influencing factors of postmenopausal osteoporosis, and ROC curve was used to analyze the predictive value of serum SIK2 and SMURF1 for postmenopausal osteoporosis. Results　Compared with the control group, the bone mineral density of lumbar L1-4 (0.71±0.20 g/cm3 vs 0.86±0.21 g/cm3), 25-hydroxyvitamin D (25- OH-D, 12.07±2.76 ng/ml vs 14.31±2.62 ng/ml) and femoral neck bone mineral density (0.61±0.18 g/cm3 vs 0.82±0.19 g/ cm3) in the study group were significantly decreased，the differences were statistically significant (t=6.378，7.254，9.895， all P<0.001). Serum osteopontin (OPN, 18.67±3.17 ng/ml vs 16.78±2.69 ng/ml), parathyroid hormone (PTH, 71.26±8.88 pg/ml vs 64.31±8.24 pg/ml), SIK2 (0.94±0.16 vs 0.79±0.17), β-CTx (5.12±0.96 pg/ml vs 4.28±0.84 pg/ml), osteocalcin (OC, 15.64±2.73 ng/ml vs 13.28±2.14 ng/ml), N-terminal propeptide of type I procollagen (PINP, 41.28±4.68 ng/ml vs 36.47±4.62 ng/ml ) and SMURF1 (0.93±0.22 vs 0.66±0.16) were significantly increased ，the differences were statistically significant (t=5.598 ～ 11.759, all P<0.001). Serum SIK2 and SMURF1 was positively correlated with OPN, OC, SMURF1, β-CTx and PINP (rSIK2=0.169 ～ 0.292，rSMURF1=0.194 ～ 0.246，all P<0.05). Serum SIK2 and SMURF1 was negatively correlated with 25- OH-D and femoral neck bone mineral density (rSIK2=-0.212，-0.210，rSMURF1=-0.285，-0.252，all P<0.05 ). Femoral neck bone mineral density (OR=0.002, P<0.05), OPN (OR=1.592, P<0.05), OC (OR=1.603, P<0.05), PINP (OR=1.675, P<0.05), SIK2 (OR=310.221, P<0.001), SMURF1 (OR=1 359.044, P<0.001) were the influencing factors of postmenopausal osteoporosis. The area under the ROC curve (AUC) of the combined prediction of postmenopausal osteoporosis was significantly larger than that of SIK2 alone (Z=3.339, P<0.001), and there was no significant difference between the combined prediction and SMURF1 alone (P>0.05). Conclusion　The serum SIK2 and SMURF1 levels in postmenopausal osteoporosis patients were significantly increased, both of which were closely related to bone metabolism index and bone mineral density.

参考文献/References:

[1] 周涛, 张兵, 朱鹏. 绝经后骨质疏松症患者血清鸢尾素、4D 同型二聚体、骨形成蛋白6 的表达及临床意义[J]. 海南医学, 2022, 33(17): 2215-2218. ZHOU Tao, ZHANG Bing, ZHU Peng. Expression and clinical significance of serum Irisin, 4D homodimer, and bone morphogenetic protein 6 in patients with postmenopausal osteoporosis [J]. Hainan Medical Journal, 2022, 33(17): 2215-2218.
[2] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444. The Chinese Medical Association of Osteoporosis and Bone Mineral Disease. Guidelines for the diagnosis and treatment of primary osteoporosis(2017)[J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2017, 10(5): 413-444.
[3] 牟朋林, 麦彩园, 曹燕明, 等. 绝经后骨质疏松患者骨组织中miR-124-3p, miR-328-3p, miR-338-3p 的表达[J]. 吉林医学, 2022, 43(7): 1771-1774. MU Penglin, MAI Caiyuan, CAO Yanming, et al. Expression of miR-124-3p, miR-328-3p and miR-338-3p in bone tissue of postmenopausal osteo porosis patients[J]. Jilin Medical Journal, 2022, 43(7): 1771-1774.
[4] 张冉, 刘云, 张翠, 等. 盐诱导激酶2 对脑缺血再灌注大鼠脑组织能量代谢的影响[J]. 浙江大学学报(医学版), 2021, 50(3): 352-360. ZHANG Ran, LIU Yun, ZHANG Cui, et al. Saltinducible kinase 2 regulates energy metabolism in rats with cerebral ischemia-reperfusion[J]. Journal of Zhejiang University(Medical Sciences), 2021, 50(3):352-360.
[5] 李超, 李忠秋, 李雪萍, 等. 盐诱导激酶2 对电离辐射诱导的自噬与凋亡的影响[J]. 辐射防护, 2017, 37(3): 214-222. LI Chao, LI Zhongqiu, LI Xueping, et al. Effects of salt-inducible kinase 2 on autophagy and apoptosis induced by ionizing radiation[J]. Radiation Protection, 2017, 37(3): 214-222.
[6] 孙智路, 尹剑, 黄开亮, 等. 脉冲电磁场抗骨质疏松作用及对Smurf 1 表达的影响[J]. 中国骨质疏松杂志, 2020, 26(8): 1093-1097. SUN Zhilu, YIN Jian, HUANG Kailiang, et al. Effect of pulsed electromagnetic field on anti-osteoporosis and expression of Smurf 1[J]. Chinese Journal of Osteoporosis, 2020, 26(8): 1093-1097.
[7] HU Wenxiong, LI Hua, JIANG Jiazheng. MiR-491-3p is down-regulated in postmenopausal osteoporosis and affects growth, differentiation and apoptosis of hFOB1.19 cells through targeting CTSS [J]. Folia Histochem Cytobiol , 2020, 58(1): 9-16.
[8] 彭玉, 梅伟群, 李志琛, 等. 重组人甲状旁腺激素(1-34) 联合雌激素对绝经后骨质疏松患者骨代谢和炎症反应的改善效果[J]. 中国妇幼保健, 2022, 37(20):3725-3728. PENG Yu, MEI Weiqun, LI Zhichen, et al. Effect of recombinant human parathyroid hormone(1-34) combined with estrogen on bone metabolism and inflammatory response in postmenopausal osteoporosis patients[J]. Maternal and Child Health Care of China, 2022, 37(20): 3725-3728.
[9] 雷欣东, 于慧, 龙琼, 等. 绝经后骨质疏松症发病机制研究进展[J]. 中国骨质疏松杂志, 2021, 27(11):1681-1684. LEI Xindong, YU Hui, LONG Qiong, et al. Research progress in the pathogenesis of postmenopausal osteoporosis [J]. Chinese Journal of Osteoporosis, 2021, 27(11): 1681-1684.
[10] 刘秀秀, 许乐, 吴敬医, 等. 下调SIK2 可减轻大鼠心肌缺血再灌注损伤: 基于mTOR-ULK1 信号通路的下调与细胞自噬的减少[J]. 南方医科大学学报,2022, 42(7): 1082-1088. LIU Xiuxiu, XU Le, WU Jingyi, et al. Down-regulation of SIK2 expression alleviates myocardial ischemiareperfusion injury in rats by inhibiting autophagy through the mTOR-ULK1 signaling pathway[J]. Journal of Southern Medical University, 2022, 42(7):1082-1088.
[11] WANG Tiantian, ZHENG Ruihe, SUN Song. Drug repurposing: escitalopram attenuates acute lung injury by inhibiting the SIK2/ HDAC4/ NF-κB signaling cascade[J]. Biochemical and Biophysical Research Communications, 2022, 599: 1-8.
[12] YANG Yuehua, SUN Yuan, MAO Weiwei, et al. Oxidative stress induces downregulation of TP53INP2 and suppresses osteogenic differentiation of BMSCs during osteoporosis through the autophagy degradation pathway[J]. Free Radical Biology & Medicine, 2021, 166: 226-237.
[13] 徐丽丽, 胥方元, 万永鲜. 人BMSCs 自噬水平和成骨分化能力比较[J]. 中国骨质疏松杂志, 2018,24(11): 1446-1450, 1463. XU Lili, XU Fangyuan, WAN Yongxian. Comparison of autophagic level and osteogenic capability in human BMSCs[J]. Chinese Journal of Osteoporosis, 2018, 24(11): 1446-1450, 1463.
[14] YE L C, QIAN L F, LIANG L, et al. Overexpression of miR-195-5p reduces osteoporosis through activating BMP-2/SMAD/Akt/RUNX2 pathway via targeting SMURF1[J]. Journal of Biological Regulators and Homeostatic Agents, 2021, 35(4): DOI:10.23812/21-162-A.
[15] LEVIN V A, JIANG X, KAGAN R. Estrogen therapy for osteoporosis in the modern era[J]. Osteoporosis International, 2018, 29(5): 1049-1055.
[16] ARMOUTI M, WINSTON N, HATANO O, et al. Saltinducible kinases are critical determinants of female fertility[J]. Endocrinology, 2020, 161(7): bqaa069.
[17] 石树培, 陈鹏, 林海仙, 等. 补肾活血方对骨质疏松症大鼠Smurf1 信号转导蛋白的影响[J]. 福建中医药,2019, 50(3): 38-40. SHI Shupei, CHEN Peng, LIN Haixian, et al. Effect of Bushen Huoxue decoction on Smurf1 signal transduction protein in osteoporosis rats[J]. Fujian Journal of Traditional Chinese Medicine, 2019, 50(3):38-40.
[18] 黄燕红, 黄丽玲, 雷美红, 等. 绝经后骨质疏松症患者血清几丁质酶壳三糖苷酶、血管活性肠肽水平与骨密度及骨代谢标志物的相关性研究[J]. 现代检验医学杂志, 2022, 37(2): 179-183, 189. HUANG Yanhong, HUANG Liling, LEI Meihong, et al. Correlation between serum levels of chitotriosidase1, vasoactive intestinal peptide and bone mineral density and bone turnover indicators in postmenopausal osteoporosis Patients[J]. Journal of Modern Laboratory Medicine, 2022, 37(2): 179-183, 189.
[19] 甘卫冬, 眭承志, 林振原, 等. 绝经后骨质疏松症患者血清ICTP, PINP 与血脂相关性的研究[J]. 中国骨质疏松杂志, 2018, 24(9): 1191-1194. GAN Weidong, SUI Chengzhi, LIN Zhenyuan, et al. Study on the correlation among serum ICTP, PINP and lipid in postmenopausal patients with osteoporosis[J]. Chinese Journal of Osteoporosis, 2018, 24(9): 1191-1194.
[20] 姚颖, 刘玮. 骨代谢生化指标与绝经后骨质疏松性腰椎骨折的关系[J]. 实用临床医药杂志, 2020, 24(7): 112-115. YAO Ying, LIU Wei. Relationship between bone metabolism biochemical indexes and osteoporotic lumbar vertebrae fracture after menopause[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 112-115.
[21] 董飞, 王玲. 绝经后女性骨转换生化标志物水平与骨密度的相关性分析[J]. 检验医学与临床, 2021,18(9): 1323-1325. DONG Fei, WANG Ling. Correlation analysis between bone turnover biochemical markers and bone mineral density in postmenopausal women[J]. Laboratory Medicine and Clinic, 2021, 18(9): 1323-1325.
[22] 廖强, 王娟. 骨质疏松患者血清25(OH)D, 骨膜素、铁蛋白水平及其与骨折发生的相关性分析[J]. 现代检验医学杂志, 2021, 36(5): 138-142. LIAO Qiang, WANG Juan. Serum levels of 25(OH)D, periostin and ferritin in patients with osteoporosis and their correlation with fracture[J]. Journal of Modern Laboratory Medicine, 2021, 36(5): 138-142.
[23] 王玉珏, 邹倩, 郭声敏, 等. 绝经后女性骨密度与骨代谢生化指标的相关性分析[J]. 中国骨质疏松杂志,2020, 26(3): 378-381. WANG Yujue, ZOU Qian, GUO Shengmin, et al. Correlation between bone mineral density and biochemical markers of bone metabolism in postmenopausal women[J]. Chinese Journal of Osteoporosis, 2020, 26(3): 378-381.

备注/Memo

备注/Memo:
作者简介：高艳超（1984-），女，硕士，副主任医师，研究方向：内分泌与代谢性疾病，E-mail：bgwkpn@163.com。
更新日期/Last Update: 2023-07-15